1.THE USE OF 6-AMINOCAPROIC ACID (EACA) TO REDUCE POSTOPERATIVE BLEEDING FOLLOWING IN MITRAL VALVE REPLACEMENT
Zhenglong DU ; Zhusheng KUANG ; Rongsheng XIONG ; Zhigang WANG ; Yibo LIU ; Hongtao XIA ; Tao BAI ; Sheng DENG ; Fu ZHANG
Chinese Journal of Postgraduates of Medicine 2001;24(5):20-21
Objective To determine the effect of 6-aminocaproic acid (EACA) to reduce postoperation bleeding following in mitral valve replacement.Method 50 adult patients uddergoing mitral valve replacement was adopted a double-bisind randomized trial to be divided into two groups.Each group is 25 patients.The patients in control groups received NS,the ones in study groups received NS as same as control groups but added EACE 10 g by intravation.The bleeding amount in cavitas thoracis were recorded on the sixth,twenty-fourth postoperative hours and ACT was recorded as well.Results The bleeding amount in study groups on the sixth postoperative hours were (290.0±41.3) ml.On twenty-fourth postoperative hours were (336.3±81.3) ml.The bleeding amount in control groups on the sixth postoperative hours were (393.4±73.6) ml.On twenty-fourth postoperative hours were (450.0±79.6) ml.The bleeding amount in study groups were decreased significantly as compared with in control groups (P<0.05).Conclusion:6-aminocaproic acid can reduce postoperation bleeding following in mitral valve replacement.
2.Therapeutic Efficacy of Reteplase versus Alteplase in the Treatment of Acute Myocardial Infarction in China :A Meta-analysis
Xuan XIONG ; Dongke YU ; Yuan ZHANG ; Yuan BIAN ; Qinan YIN ; Yao CHEN ; Rongsheng TONG
China Pharmacy 2019;30(9):1279-1284
OBJECTIVE: To evaluate therapeutic efficacy of reteplase versus alteplase in the treatment of acute myocardial infarction in China, and to provide evidence-based reference for clinical treatment. METHODS: Retrieved from Cochrane library, PubMed, Embase, Medline, CJFD, CSJD, Wanfang database by computor, etc., also by manual search, RCTs about therapeutic efficacy (recanalization rate of thrombolysis) of reteplase (trial group) versus alteplase (control group) in the treatment of acute myocardial infarction in China were collected from Jan. 1995 to Sept. 2018. After data extraction and quality evaluation with Cochrane system evaluator manual 5.1.0, Meta-analysis was performed for recanalization rate of thrombolysis by using Rev Man 5.3 software. RESULTS: A total of 23 RCTs were included, involving 1 742 patients. Results of Meta-analysis showed that recanalization rate of thrombolysis in trial group was significantly higher than control group, with statistical significance [OR=0.61,95%CI(0.50,0.73),P<0.001]. Sub-group Meta-analysis was performed according to the successful time of thrombolysis. Results of Meta-analysis showed that recanalization rate of thrombolysis in trial group 1 h [OR=0.38,95%CI(0.25,0.58),P<0.001], 1.5 h [OR=0.44,95%CI(0.25,0.79),P=0.006] and 2 h [OR=0.62,95%CI(0.42,0.92),P=0.02] after thrombolysis were significantly higher than control group, with statistical significance. CONCLUSIONS: The recanalization rate of thrombolysis by reteplase in Chinese patients with acute myocardial infarction in better than by alteplase.